Immunogenic cell death activates the tumor immune microenvironment to boost the immunotherapy efficiency

Z Li, X Lai, S Fu, L Ren, H Cai, H Zhang, Z Gu… - Advanced …, 2022 - Wiley Online Library
Tumor immunotherapy is only effective in a fraction of patients due to a low response rate
and severe side effects, and these challenges of immunotherapy in clinics can be addressed …

[HTML][HTML] Natural and synthetic nanovectors for cancer therapy

A Eftekhari, C Kryschi, D Pamies, S Gulec… - …, 2023 - ncbi.nlm.nih.gov
Nanomaterials have been extensively studied in cancer therapy as vectors that may improve
drug delivery. Such vectors not only bring numerous advantages such as stability …

Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy

E Pérez-Herrero, A Fernández-Medarde - European journal of …, 2015 - Elsevier
Cancer is the second worldwide cause of death, exceeded only by cardiovascular diseases.
It is characterized by uncontrolled cell proliferation and an absence of cell death that, except …

Preparation, characterization, and potential application of chitosan, chitosan derivatives, and chitosan metal nanoparticles in pharmaceutical drug delivery

TA Ahmed, BM Aljaeid - Drug design, development and therapy, 2016 - Taylor & Francis
Naturally occurring polymers, particularly of the polysaccharide type, have been used
pharmaceutically for the delivery of a wide variety of therapeutic agents. Chitosan, the …

[HTML][HTML] Functionalized niosomes as a smart delivery device in cancer and fungal infection

P Aparajay, A Dev - European journal of pharmaceutical sciences, 2022 - Elsevier
Various diseases remain untreated due to lack of suitable therapeutic moiety or a suitable
drug delivery device, especially where toxicities and side effects are the primary reason for …

Tumor targeting strategies of smart fluorescent nanoparticles and their applications in cancer diagnosis and treatment

J He, C Li, L Ding, Y Huang, X Yin, J Zhang… - Advanced …, 2019 - Wiley Online Library
Advantages such as strong signal strength, resistance to photobleaching, tunable
fluorescence emissions, high sensitivity, and biocompatibility are the driving forces for the …

Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging

S Parveen, R Misra, SK Sahoo - Nanomedicine in cancer, 2017 - api.taylorfrancis.com
Drug delivery is an intriguing field of research that has captured the interest of researchers
because delivering a medicine to its site of therapeutic action is one of the main limitations of …

Chitosan-based nanoparticles: An overview of biomedical applications and its preparation

S Naskar, S Sharma, K Kuotsu - Journal of Drug Delivery Science and …, 2019 - Elsevier
Chitosan (CS) is one of the most successfully developed biodegradable polymers. Among
the numerous polymers developed to formulate polymeric nanoparticles, CS has fascinated …

Targeting and delivery of platinum-based anticancer drugs

X Wang, Z Guo - Chemical Society Reviews, 2013 - pubs.rsc.org
Platinum-based anticancer drugs occupy a crucial role in the treatment of various malignant
tumours. However, the efficacy and applicability of platinum drugs are heavily restricted by …

Recent advances of chitosan nanoparticles as drug carriers

JJ Wang, ZW Zeng, RZ Xiao, T Xie… - International journal …, 2011 - Taylor & Francis
Chitosan nanoparticles are good drug carriers because of their good biocompatibility and
biodegradability, and can be readily modified. As a new drug delivery system, they have …